The p53 tumour-suppressor gene integrates numerous signals that control cell life and death. As when a highly connected node in the Internet breaks down, the disruption of p53 has severe consequences.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2
Journal of Translational Medicine Open Access 21 March 2024
-
Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML)
Cell Death & Disease Open Access 10 January 2024
-
Knockdown of MRPL35 promotes cell apoptosis and inhibits cell proliferation in non-small-cell lung cancer
BMC Pulmonary Medicine Open Access 13 December 2023
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hollstein, M. et al. Mutat. Res. 431, 199– 209 (1999).
Hussain, S. P. & Harris, C. C. Mutat. Res. 428, 23–32 (1999).
Carr, A. M. Science 287, 1765–1766 ( 2000).
Sherr, C. J. & Weber, J. D. Curr. Opin. Genet. Dev. 10, 94–99 (2000).
Lowe, S. W. & Lin, A. W. Carcinogenesis 21, 485–495 (2000).
Meek, D. W. Oncogene 18, 7666–7675 ( 1999).
Momand, J., Wu, H. H. & Dasgupta, G. Gene 242, 15– 29 (2000).
Prives, C. & Hall, P. A. J. Pathol. 187, 112–126 (1999).
Giaccia, A. J. & Kastan, M. B. Genes Dev. 12, 2973–2983 (1998).
Selivanova, G., Kawasaki, T., Ryabchenko, L. & Wiman, K. G. Semin. Cancer Biol. 8, 369–378 (1998).
Buschmann, T., Fuchs, S. Y., Lee, C. G., Pan, Z. Q. & Ronai, Z. Cell 101, 753– 762 (2000).
Bar-Or, R. L. et al. Proc. Natl Acad. Sci. USA 97, 11250 –11255 (2000).
Lozano, G. & Liu, G. Semin. Cancer Biol. 8, 337–344 (1998).
Bell, D. W. et al. Science 286, 2528– 2531 (1999).
Vousden, H. & Van de Woude, G. F. Nature Cell Biol. 2, E178–E180 (2000).
Levine, A. J. Cell 88, 323–331 ( 1997).
El-Deiry, W. S. Semin. Cancer Biol. 8, 345–357 (1998).
Ohki, R. et al. J. Biol. Chem. 275, 22627– 22630 (2000).
Chan, T. A. et al. Nature 401, 616–620 (1999).
Laronga, C. et al. J. Biol. Chem. 275, 23106– 23112 (2000).
Dellambra, E. et al. J. Cell Biol. 149, 1117– 1130 (2000).
Gottlieb, T. M. & Oren, M. Semin. Cancer Biol. 8, 359–368 ( 1998).
Reed, J. C. J. Clin. Oncol. 17, 2941–2953 (1999).
Schmidt, T. et al. Cell Death Differ. 6, 873– 882 (1999).
Oda, E. et al. Science 288, 1053–1058 (2000).
Oda, K. et al. Cell 102, 849–862 (2000).
Lin, Y., Ma, W. & Benchimol, S. Nature Genet. 26, 122– 127 (2000).
Tlsty, T. D. Curr. Top. Microbiol. Immunol. 221, 37– 46 (1997).
Wahl, G. M. et al. Cancer Surv. 29, 183– 219 (1997).
Tanaka, H. et al. Nature 404, 42–49 (2000).
Lozano, G. & Elledge, S. J. Nature 404, 24–25 (2000).
Hendrix, M. J. Nature Med. 6, 374–376 ( 2000).
Schwarte-Waldhoff, I. et al. Proc. Natl Acad. Sci. USA 97, 9624– 9629 (2000).
Yu, J. et al. Proc. Natl Acad. Sci. USA 96, 14517– 14522 (1999).
Zhao, R. et al. Genes Dev. 14, 981–993 (2000).
Albert, R. et al. Nature 406, 378–382 (2000).
Tu, Y. Nature 406, 353–354 ( 2000).
Dotto, G. P. Crit. Rev. Oral Biol. Med. 10, 442– 457 (1999).
Jones, J. M. et al. Cell Growth Differ. 10, 213– 222 (1999).
Franklin, D. S. et al. Mol. Cell Biol. 20, 6147– 6158 (2000).
Lamont, J. P. et al. Ann. Surg. Oncol. 7, 588– 592 (2000).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Vogelstein, B., Lane, D. & Levine, A. Surfing the p53 network. Nature 408, 307–310 (2000). https://doi.org/10.1038/35042675
Issue Date:
DOI: https://doi.org/10.1038/35042675
This article is cited by
-
AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2
Journal of Translational Medicine (2024)
-
Translating p53-based therapies for cancer into the clinic
Nature Reviews Cancer (2024)
-
Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML)
Cell Death & Disease (2024)
-
Chimeric TβRII-SE/Fc overexpression by a lentiviral vector exerts strong antitumoral activity on colorectal cancer-derived cell lines in vitro and on xenografts
Cancer Gene Therapy (2024)
-
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
European Journal of Nuclear Medicine and Molecular Imaging (2024)